Perfil
Christopher Sweeney is Medical Director of Semafore Pharmaceuticals, Inc. and Clinical Director of the Developmental Therapeutics Program for the Division of Hematology and Oncology of the IU Medical School Cancer Center.
He was an Internal Medicine Resident of the Gundersen Lutheran Medical Center from 1994 to 1997 and a Fellow in Hematology and Oncology of the Indiana University Medical Center from 1997 to 2000.
He received an MD from the University of Adelaide in 1992.
Antiguos cargos conocidos de Christopher Sweeney.
| Empresas | Cargo | Fin |
|---|---|---|
Semafore Pharmaceuticals, Inc.
 Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Formación de Christopher Sweeney.
| University of Adelaide | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
- Bolsa de valores
- Insiders
- Christopher Sweeney